UnitedHealth Group Incorporated (UNH)
Automate Your Wheel Strategy on UNH
With Tiblio's Option Bot, you can configure your own wheel strategy including UNH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol UNH
- Rev/Share 479.25
- Book/Share 111.8601
- PB 2.8748
- Debt/Equity 0.789
- CurrentRatio 0.8229
- ROIC 0.1051
- MktCap 291299583420.0
- FreeCF/Share 19.1322
- PFCF 16.7683
- PE 16.601
- Debt/Assets 0.2542
- DivYield 0.0268
- ROE 0.1832
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 3
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | UNH | Deutsche Bank | Buy | Hold | -- | $333 | Oct. 29, 2025 |
| Initiation | UNH | Goldman | -- | Buy | -- | $406 | Oct. 14, 2025 |
| Downgrade | UNH | Robert W. Baird | Neutral | Underperform | -- | $198 | July 31, 2025 |
| Reiterated | UNH | Oppenheimer | -- | Outperform | $400 | $325 | July 30, 2025 |
| Downgrade | UNH | Robert W. Baird | Outperform | Neutral | -- | $312 | June 11, 2025 |
| Downgrade | UNH | HSBC Securities | Hold | Reduce | -- | $270 | May 21, 2025 |
| Downgrade | UNH | TD Cowen | Buy | Hold | -- | $308 | May 19, 2025 |
| Downgrade | UNH | BofA Securities | Buy | Neutral | -- | $350 | May 14, 2025 |
| Downgrade | UNH | Raymond James | Strong Buy | Market Perform | -- | -- | May 14, 2025 |
| Downgrade | UNH | HSBC Securities | Buy | Hold | -- | $490 | April 22, 2025 |
News
UnitedHealth Group Incorporated (UNH) Presents at UBS Global Healthcare Conference 2025 Transcript
Published: November 11, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth Group Incorporated ( UNH ) UBS Global Healthcare Conference 2025 November 10, 2025 8:45 AM EST Company Participants Julie Murphy Wayne DeVeydt - Chief Financial Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division All right. I think we're ready to get going.
Read More
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
Published: November 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Read More
UnitedHealth's Q3 Beat Isn't Stopping the Bleed: Hold or Fold Now?
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Neutral
UNH's Q3 earnings beat couldn't stop a 9.6% stock slide as rising medical costs and margin strain test investor patience.
Read More
Buy Or Sell United Health Stock?
Published: November 05, 2025 by: Forbes
Sentiment: Neutral
UnitedHealth (UNH) shares have dropped 10% over the last week and are presently trading at $330.83. We believe there are only a few aspects to be wary of in UNH stock, considering its overall Moderate operating performance and financial health.
Read More
UnitedHealth: The Market Is Still Worried, And That's Good For Buyers
Published: November 04, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth Group is showing solid signs of stabilization after July's capitulation, with Berkshire's investment boosting sentiments and a resilient Q3 performance lending a calming influence. UNH's medical cost ratio improvement and double-digit earnings growth expected by 2027 underpin a positive long-term outlook, despite current margin pressures. Valuation has rebounded near its 10-year average, suggesting near-term consolidation, but 2027 EPS forecasts indicate the opportunity for long-term holders is still nascent.
Read More
UnitedHealth Group Q3: Why Strong Money Holds At $323
Published: November 03, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group remains a buy, supported by recent super-investor accumulation and their holding price. Super-investors, including Berkshire Hathaway and Michael Burry, currently hold UNH shares at $323, or 19.8x FWD P/E. Given the business updates provided in the company's Q3 ER, my risk calculus shows a very skewed risk/return profile at this holding P/E.
Read More
UnitedHealth: A Glimmer Of Future Growth Is Still There
Published: November 03, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth's Q3 earnings surpassed expectations, breaking a missing streak and signaling a potential operational turnaround under new leadership. UNH's new management, led by returning CEO Stephen Hemsley, is focusing on profitability, cost control, and margin improvement through operational turnaround. Despite anticipated Medicare Advantage membership contraction, strategic repricing and AI investments are poised to enhance future profitability and demand.
Read More
The Richest 0.1% Are Buying These 3 Dividend Stocks Right Now
Published: October 30, 2025 by: 24/7 Wall Street
Sentiment: Positive
When ultra-rich investors start coalescing into the same names or put an unusually large amount of money into a single stock, that should raise more interest.
Read More
Here Are Wednesday's Top Wall Street Analyst Research Calls: United Health, SoFi, Skyworks, Energy Transfer and More
Published: October 29, 2025 by: 24/7 Wall Street
Sentiment: Positive
The futures are trading higher this morning after another stellar day across Wall Street on Tuesday, as all the major indices once again ended higher and continue to print new all-time highs.
Read More
UnitedHealth Group's Recovery in Full Swing: Buy While It's Down
Published: October 29, 2025 by: MarketBeat
Sentiment: Neutral
If UnitedHealth Group's NYSE: UNH stock price implosion was driven by margin, earnings, and capital return concerns, the Q3 results put them to rest.
Read More
UnitedHealth: Strong Long-Term Fundamentals, But Risks Also Exist
Published: October 29, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group has outperformed the S&P 500 since my previous Buy and Strong Buy ratings, delivering 33% and 41% total returns. Following Q3 FY2025 earnings review, UNH remains the most expensive among peers ELV, CNC, and MOH based on valuation multiples. Despite strong long-term fundamentals, current risks include elevated medical costs, potential for lower earnings, and risk of multiple compression.
Read More
UnitedHealth Revenue Rises 12% Amid AI Investments
Published: October 28, 2025 by: PYMNTS
Sentiment: Positive
UnitedHealth Group says tech investments are key to its ongoing turnaround strategy. The insurer announced quarterly earnings Tuesday (Oct. 28) showing consolidated revenues of $113.2 billion, a 12% increase year over year.
Read More
UnitedHealthcare May Lose Two-Thirds Of Obamacare Enrollees After Price Hikes
Published: October 28, 2025 by: Forbes
Sentiment: Negative
UnitedHealthcare, the nation's largest health insurer, said rate increases of more than 25% and “targeted service area” reductions could reduce its Obamacare customer base by about “two-thirds.”
Read More
UnitedHealth Q3 Earnings Beat on Rising Commercial Membership
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH's Q3 earnings beat estimates on solid commercial membership gains and Optum Rx strength, though profits fall sharply on rising medical costs.
Read More
You Can Spell UnitedHealth Without AI
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth delivered a Q3 double beat and raised full-year guidance, signaling improving cost efficiency despite ongoing sector-wide margin pressures. UNH remains undervalued due to sector headwinds and lack of AI narrative, yet its scale, pricing power, and resilient business model offer long-term upside. Optum's restructuring and disciplined capital management position UNH for margin restoration and sustainable growth, with operational gains already visible.
Read More
UnitedHealth: Great News, Finally
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group Incorporated delivered strong Q3 results, beating both revenue and earnings estimates and raising guidance, signaling a potential turnaround. UNH reported 12% year-over-year revenue growth and a 4% earnings per share beat, reversing a trend of recent estimate misses. The stock has outperformed the market recently, returning 22% in under three months compared to the S&P 500's 7% gain.
Read More
UnitedHealth's Q3 earnings report shows turnaround efforts are gaining steam
Published: October 28, 2025 by: Fast Company
Sentiment: Positive
UnitedHealth on Tuesday raised its annual profit forecast and said it aims to grow in 2026, in a sign that the turnaround efforts under new CEO Stephen Hemsley were gaining steam.
Read More
UnitedHealth Earnings Top Expectations, as Insurer Works Toward a Turnaround
Published: October 28, 2025 by: Investopedia
Sentiment: Positive
America's biggest insurer is showing some signs of improvement in the health of its business, after a series of setbacks.
Read More
UnitedHealth Group Incorporated (UNH) Q3 2025 Earnings Call Transcript
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Neutral
UnitedHealth Group Incorporated (NYSE:UNH ) Q3 2025 Earnings Call October 28, 2025 8:00 AM EDT Company Participants Stephen Hemsley - CEO & Non-Independent Non-Executive Chairman Timothy Noel - Chief Executive Officer of UnitedHealthcare Business Patrick Conway - Chief Executive Officer of Optum Rx Wayne DeVeydt - Chief Financial Officer Krista Nelson - Chief Executive Officer of UnitedHealthcare Community & State Sandeep Dadlani - Executive VP and Chief Digital & Technology Officer Robert Hunter Dan Schumacher - President Conference Call Participants Joshua Raskin - Nephron Research LLC Albert Rice - UBS Investment Bank, Research Division Justin Lake - Wolfe Research, LLC …
Read More
UnitedHealth Boosts Guidance And Eyes Big 2026
Published: October 28, 2025 by: 24/7 Wall Street
Sentiment: Positive
UnitedHealth beat EPS expectations and raised full-year guidance, signaling early signs of stabilization.
Read More
UnitedHealth raises full-year guidance as Q3 earnings beat estimates
Published: October 28, 2025 by: Proactive Investors
Sentiment: Positive
UnitedHealth Group Inc (NYSE:UNH, ETR:UNH) reported third-quarter revenue and adjusted earnings per share that beat Wall Street expectations, driven by growth in its health benefits and pharmacy services, and raised its full-year guidance. Revenue rose 12% from a year earlier to $113.2 billion, narrowly above analysts' estimate of $113.16 billion.
Read More
Insurance Stock Drifts Lower After Revenue Miss
Published: October 28, 2025 by: Schaeffers Research
Sentiment: Negative
Shares of UnitedHealth Group Inc (NYSE:UNH) were last seen down 0.5% to trade at $364.11, after the company announced third-quarter results of $2.92 per share on $113.2 billion in revenue, the former beating estimates and the latter falling short.
Read More
UnitedHealth: Nothing Is Over
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group Incorporated delivered Q3 revenue of $113.2 billion, up 12.3% year-over-year, slightly ahead of consensus estimates despite ongoing regulatory and cost challenges. UNH's Q3 EPS of $2.92 beat expectations, signaling stabilization, while the medical care ratio remained elevated at 89.9% but in line with forecasts. Management raised 2025 guidance, expecting adjusted EPS of at least $16.25 and total revenues around $447 billion, with Optum Rx as a key growth driver.
Read More
UnitedHealth (UNH) Reports Q3 Earnings: What Key Metrics Have to Say
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for UnitedHealth (UNH) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
UnitedHealth Q3: The Falling Knife Has Finally Stopped Falling
Published: October 28, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group Incorporated delivered strong Q3 2025 results, beating expectations, raising guidance, and stabilizing key metrics after a challenging year. UNH's medical care ratio aligned with guidance, revenue grew 12.3% year over year, and both insurance and Optum segments showed solid performance. Investor sentiment has shifted positively, with UNH stock outperforming peers and now trading above average analyst price targets, sparking potential upgrades.
Read More
United Health Jumps After Big Q3 Earnings
Published: October 28, 2025 by: 24/7 Wall Street
Sentiment: Negative
EPS beat by $0.10, but operating income plunged 50% year-over-year to $4.3B.
Read More
UnitedHealth Vs. Centene: Next Week's Q3 Earnings Should Trigger Gains For Both
Published: October 24, 2025 by: Seeking Alpha
Sentiment: Positive
UnitedHealth Group Incorporated and Centene Corporation remain heavily discounted after recent selloffs, but are poised for recovery ahead of Q3 earnings. Both UNH and CNC withdrew guidance in 2025 due to rising healthcare utilization and margin pressure, but recent signals suggest stabilization and improving outlooks. CMS's commitment to higher Medicare Advantage rates in 2026 and improving Medicaid margins supports a bullish stance on both stocks.
Read More
UnitedHealth Recovers Its Rhythm Before Q3 Earnings: Time to Buy?
Published: October 24, 2025 by: Zacks Investment Research
Sentiment: Positive
UNH's Q3 results hinge on premium growth and Optum gains amid rising costs and margin pressure.
Read More
What Analyst Projections for Key Metrics Reveal About UnitedHealth (UNH) Q3 Earnings
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for UnitedHealth (UNH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Read More
What's Behind The 30% Surge In UNH Stock?
Published: October 23, 2025 by: Forbes
Sentiment: Positive
UnitedHealth (UNH)'s stock jumped 31% in three months, driven not only by a slight increase in revenue and a high P/E multiple, but also amid mixed signals: a Q2 earnings miss, regulatory scrutiny, and renewed investments in AI. What's behind this volatility?
Read More
About UnitedHealth Group Incorporated (UNH)
- IPO Date 1984-10-17
- Website https://www.unitedhealthgroup.com
- Industry Medical - Healthcare Plans
- CEO Stephen J. Hemsley
- Employees 400000